These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37976808)

  • 1. 4-Arylidene curcumin derivatives in vitro inhibit α-Synuclein aggregation and disaggregate the preformed fibril.
    Liu W; Zhang W; Xing LZ; Zhao YD; Xu J; Li RJ; Zhang YX
    Bioorg Med Chem; 2023 Dec; 96():117529. PubMed ID: 37976808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrids of polyphenolic acids and xanthone, the potential preventive and therapeutic effects on PD: Design, synthesis, in vitro anti-aggregation of α-synuclein, and disaggregation against the existed α-synuclein oligomer and fibril.
    Han F; Jiang B; Lü MH; Wang ZP; Liu W; Zhang YX; Xu J
    Bioorg Med Chem; 2022 Jul; 66():116818. PubMed ID: 35584603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-chalcone polyphenols with potential preventive and therapeutic effects on PD: Design, synthesis and in vitro disaggregation activity against α-synuclein oligomers and fibrils.
    Jiang B; Han F; Lü MH; Wang ZP; Liu W; Zhang YX; Xu J; Li RJ
    Eur J Med Chem; 2022 Sep; 239():114529. PubMed ID: 35728509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole.
    Zhao YD; Zhang W; Xing LZ; Xu J; Shi WM; Zhang YX
    Bioorg Med Chem Lett; 2024 Jun; 105():129752. PubMed ID: 38631541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers.
    Zhang W; Liu W; Zhao YD; Xing LZ; Xu J; Li RJ; Zhang YX
    Bioorg Med Chem Lett; 2024 Jan; 97():129564. PubMed ID: 38000482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of Coumarin-polyphenolic acid hybrids in PD: Inhibition of α-Syn aggregation and disaggregation of preformed fibrils, leading to reduced neuronal inclusion formation.
    Wang ZP; Zhang W; Xing LZ; Zhao YD; Xu J; Zhang YX
    Bioorg Med Chem Lett; 2024 Feb; 99():129618. PubMed ID: 38219887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazolamide derivatives inhibit α-Synuclein aggregation, disaggregate preformed fibers, and reduce inclusion formation in neuron cells.
    Xing LZ; Zhang W; Zhao YD; Xu J; Zhang YX
    Eur J Med Chem; 2024 Mar; 268():116198. PubMed ID: 38368711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity.
    Jha NN; Ghosh D; Das S; Anoop A; Jacob RS; Singh PK; Ayyagari N; Namboothiri IN; Maji SK
    Sci Rep; 2016 Jun; 6():28511. PubMed ID: 27338805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrids of polyphenolic/quinone acids, the potential preventive and therapeutic drugs for PD: Disaggregate α-Syn fibrils, inhibit inclusions, and repair damaged neurons in mice.
    Lü MH; Wang ZP; Xing LZ; Zhang W; Han F; Huang GL; Liu W; Zhang YX; Xu J; Cui J
    Eur J Med Chem; 2023 Mar; 249():115122. PubMed ID: 36680987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin modulates α-synuclein aggregation and toxicity.
    Singh PK; Kotia V; Ghosh D; Mohite GM; Kumar A; Maji SK
    ACS Chem Neurosci; 2013 Mar; 4(3):393-407. PubMed ID: 23509976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.
    Ardah MT; Ghanem SS; Abdulla SA; Lv G; Emara MM; Paleologou KE; Vaikath NN; Lu JH; Li M; Vekrellis K; Eliezer D; El-Agnaf OMA
    BMC Complement Med Ther; 2020 Mar; 20(1):73. PubMed ID: 32143619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
    Chaari A; Eliezer D; Ladjimi M
    Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
    Zaidi FK; Deep S
    Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
    Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
    Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
    Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK
    ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
    Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
    J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states.
    Haque R; Maity D
    Bioorg Med Chem Lett; 2023 Apr; 86():129257. PubMed ID: 36966976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyphenols-Based Nanosheets of Propolis Modulate Cytotoxic Amyloid Fibril Assembly of α-Synuclein.
    Rafiei Y; Salmani B; Mirzaei-Behbahani B; Taleb M; Meratan AA; Ramezani M; Nikfarjam N; Becker S; Rezaei-Ghaleh N
    ACS Chem Neurosci; 2022 Nov; 13(22):3168-3179. PubMed ID: 36314062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.